Manhattan Scientifics, Inc. Announces Collaboration With MD Anderson Cancer Center To Validate New Instrument For Very Early Detection Of Cancer

ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics (OTC: MHTX) executed an agreement to collaborate with The University of Texas MD Anderson Cancer Center (MDACC) to advance, demonstrate and validate a breakthrough technology developed by Edward R. Flynn, PhD, for the very early detection of cancer. Dr. Flynn is the founder and chief scientist of MHTX’s subsidiary, Senior Scientific LLC. Senior Scientific is seeking to commercialize this patented non-invasive technology using ultra-sensitive magnetic detectors to locate, identify and measure tumors thousands of times smaller than detectable using current technologies.

Help employers find you! Check out all the jobs and post your resume.